ECM
ExodusPoint Capital Management Portfolio holdings
AUM
$8.21B
1-Year Return
14.38%
This Quarter Return
+3.14%
1 Year Return
+14.38%
3 Year Return
+47.96%
5 Year Return
+100.26%
10 Year Return
–
AUM
$8.56B
AUM Growth
-$194M
(-2.2%)
Cap. Flow
-$460M
Cap. Flow
% of AUM
-5.37%
Top 10 Holdings %
Top 10 Hldgs %
12.91%
Holding
2,266
New
641
Increased
479
Reduced
581
Closed
549
Top Buys
| 1 |
Global Payments
GPN
|
+$295M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$75.5M |
| 3 |
American Homes 4 Rent
AMH
|
+$72.5M |
| 4 |
Equinix
EQIX
|
+$54.8M |
| 5 |
Americold
COLD
|
+$52.5M |
Top Sells
| 1 |
NiSource
NI
|
+$76.6M |
| 2 |
Linde
LIN
|
+$74M |
| 3 |
DTE Energy
DTE
|
+$56.4M |
| 4 |
Freeport-McMoran
FCX
|
+$54.3M |
| 5 |
FedEx
FDX
|
+$48.7M |
Sector Composition
| 1 | Industrials | 15.92% |
| 2 | Technology | 13.97% |
| 3 | Healthcare | 13.1% |
| 4 | Real Estate | 9.85% |
| 5 | Utilities | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
John Wiley & Sons Class A
WLY
$2.24B
| $424K | ﹤0.01% |
12,463
+859
| +7% | +$29.2K |
|
|
NVRO
1327
DELISTED
NEVRO CORP.
NVRO
| $424K | ﹤0.01% |
16,689
-41,651
| -71% | -$1.06M |
|
|
HTO
1328
H2O America Common Stock
HTO
$1.76B
| $422K | ﹤0.01% |
6,016
-1,400
| -19% | -$98.2K |
|
1329
Cullinan Oncology
CGEM
$391M
| $421K | ﹤0.01% |
39,161
-4,991
| -11% | -$53.7K |
|
1330
Gannett
GCI
$632M
| $420K | ﹤0.01% |
+186,857
| New | +$420K |
|
1331
Ameriprise Financial
AMP
$47.2B
| $417K | ﹤0.01% |
1,254
-20,231
| -94% | -$6.73M |
|
1332
Nurix Therapeutics
NRIX
$703M
| $417K | ﹤0.01% |
+41,718
| New | +$417K |
|
1333
Blue Owl Capital
OBDC
$7.29B
| $414K | ﹤0.01% |
30,850
-59,669
| -66% | -$801K |
|
|
SA
1334
Seabridge Gold
SA
$1.9B
| $413K | ﹤0.01% |
34,256
-16,878
| -33% | -$203K |
|
1335
Clearwater Paper
CLW
$351M
| $410K | ﹤0.01% |
+13,096
| New | +$410K |
|
1336
Bloom Energy
BE
$15.7B
| $408K | ﹤0.01% |
24,961
+2
| +0% | +$33 |
|
|
INFN
1337
DELISTED
Infinera Corporation Common Stock
INFN
| $407K | ﹤0.01% |
84,205
-560,808
| -87% | -$2.71M |
|
1338
Protagonist Therapeutics
PTGX
$3.71B
| $405K | ﹤0.01% |
+14,654
| New | +$405K |
|
1339
Destination XL Group
DXLG
$74.9M
| $404K | ﹤0.01% |
+82,407
| New | +$404K |
|
1340
Leidos
LDOS
$23.8B
| $404K | ﹤0.01% |
4,570
-31,849
| -87% | -$2.82M |
|
1341
Stellantis
STLA
$27.6B
| $404K | ﹤0.01% |
23,026
-17,256
| -43% | -$303K |
|
1342
Eastman Chemical
EMN
$7.8B
| $403K | ﹤0.01% |
+4,812
| New | +$403K |
|
1343
Addus HomeCare
ADUS
$2.07B
| $402K | ﹤0.01% |
+4,336
| New | +$402K |
|
|
MTTR
1344
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $401K | ﹤0.01% |
+127,387
| New | +$401K |
|
1345
FB Financial Corp
FBK
$2.87B
| $400K | ﹤0.01% |
+14,258
| New | +$400K |
|
1346
MannKind Corp
MNKD
$1.66B
| $400K | ﹤0.01% |
98,333
-441,653
| -82% | -$1.8M |
|
1347
Chefs' Warehouse
CHEF
$2.69B
| $399K | ﹤0.01% |
11,171
-37,155
| -77% | -$1.33M |
|
|
FPI
1348
Farmland Partners
FPI
$482M
| $399K | ﹤0.01% |
+32,697
| New | +$399K |
|
1349
Synaptics
SYNA
$2.76B
| $398K | ﹤0.01% |
4,665
-32,608
| -87% | -$2.78M |
|
1350
Treace Medical Concepts
TMCI
$470M
| $398K | ﹤0.01% |
15,543
+376
| +2% | +$9.63K |
|